When companies like OpenAI and Anthropic pull products due to risk, it's a clear signal that they are unable to self-govern. This action is interpreted as a plea for government oversight, as relying on the social conscience of a few CEOs is an unsustainable model.

A16z proposes a federalist approach to AI governance. The federal government, under the Commerce Clause, should regulate AI *development* to create a single national market. States should focus on regulating the harmful *use* of AI, which aligns with their traditional role in areas like criminal law.

In regulated industries like finance, the primary barrier to full AI automation is often regulation, not just user trust. It is the technology provider's responsibility to prove AI's reliability and safety to regulators, much like the industry did to legitimize e-signatures over a decade ago.

Responsibility for ethical AI extends to users. Dr. el Kaliouby argues consumers hold significant power by choosing which AI tools to pay for and use. This collective action can force companies to prioritize ethics, data privacy, and bias mitigation to win market share.

Government procurement is deterministic, while LLMs are probabilistic. To bridge this gap, introduce AI not as a decision-maker but as a tool to accelerate human tasks. Focus on AI assisting with research, note-taking, and initial drafting, keeping a human firmly in the loop to ensure compliance.

Instead of trying to legally define and ban 'superintelligence,' a more practical approach is to prohibit specific, catastrophic outcomes like overthrowing the government. This shifts the burden of proof to AI developers, forcing them to demonstrate their systems cannot cause these predefined harms, sidestepping definitional debates.

Security leaders don't wait for government mandates; they adopt market-driven standards like SOC 2 to protect their business and customers. AI governance is following a similar path, with companies establishing robust practices out of necessity, not just for compliance.

Technical research is vital for governance because it provides concrete artifacts for policymakers. Demonstrations and evaluations showing dangerous AI behaviors make abstract risks tangible, giving policymakers a clear target for regulation, aligning with advice from figures like Jake Sullivan.

An FDA-style regulatory model would force AI companies to make a quantitative safety case for their models before deployment. This shifts the burden of proof from regulators to creators, creating powerful financial incentives for labs to invest heavily in safety research, much like pharmaceutical companies invest in clinical trials.